Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Phenytoin (Dilantin) and acupuncture therapy in the treatment of intractable oral and facial pain.
[Multiple sclerosis : actuality and therapeutic prospects].
Long-term follow-up of vanishing tumors in the brain: How should a lesion mimicking primary CNS lymphoma be managed?
The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P₁) and hypertension (S1P₃) in rat.
Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study.
Sanofi sees US FDA ruling for MS drug Lemtrada in Q4
A Network Meta-Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta-1a versus Other Injectable Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis.
Santhera enters agreement with Columbia University to investigate additional potential of Catena® in MELAS
Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years.
The effects of massage therapy on multiple sclerosis patients' quality of life and leg function.
Managing fatigue in patients with multiple sclerosis.
The unidimensional self-efficacy scale for MS (USE-MS): developing a patient based and patient reported outcome.
UPDATE 2-FDA panel supports approval of Sanofi's MS drug Lemtrada
Vitamin D and multiple sclerosis: a critical review and recommendations on treatment.
Chronic cerebrospinal venous insufficiency: masked multimodal imaging assessment.
Design and screening of a glial cell-specific, cell penetrating Peptide for therapeutic applications in multiple sclerosis.
CLARITY – Safety and Efficacy of Oral Cladribine in Subjects with Relapsing-remitting Multiple Sclerosis (MS)
Laminin-411 Is a Vascular Ligand for MCAM and Facilitates TH17 Cell Entry into the CNS.
Recurrence of disease activity after repeated Natalizumab withdrawals.
Amiloride HCI Tablets, USP 5 mg
Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis).
Self-perceived performance and satisfaction with performance of daily activities in persons with multiple sclerosis following interdisciplinary rehabilitation.
Calpain inhibition attenuated morphological and molecular changes in skeletal muscle of experimental allergic encephalomyelitis rats.
Central Nervous System Herpes Simplex and Varicella-Zoster Virus Infections in Natalizumab-Treated Patients.
An observational study to assess persistence, adherence, quality of life, and treatment satisfaction in patients beginning therapy with the Avonex® PEN™ (PERSIST)

Pages